VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q85875220  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000339.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q85875220‏
024 ‎‡a  0000-0002-3651-7701‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q85875220‏
100 0 ‎‡a  Ming Zheng‏ ‎‡c  researcher (ORCID 0000-0002-3651-7701)‏ ‎‡9  en‏
670 ‎‡a  Author's CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma‏
670 ‎‡a  Author's Conversion of effector CD4+ T cells to a CD8+ MHC II-recognizing lineage‏
670 ‎‡a  Author's Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis‏
670 ‎‡a  Author's High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.‏
670 ‎‡a  Author's [Highly expressed CD147 on CD4⁺ tumor infiltrating lymphocytes promotes the progress of breast cancer]‏
670 ‎‡a  Author's Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV‏
670 ‎‡a  Author's RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression‏
670 ‎‡a  Author's TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis‏
909 ‎‡a  (orcid) 0000000236517701‏ ‎‡9  1‏
919 ‎‡a  highgins2transcriptlevelpredictspoorprognosisandcorrelateswithhighhistologicalgradeandendocrinetherapyresistancethroughmammarycancerstemcellsinbreastcancerpatients‏ ‎‡A  High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.‏ ‎‡9  1‏
919 ‎‡a  highlyexpressedcd147oncd4+tumorinfiltratinglymphocytespromotestheprogressofbreastcancer‏ ‎‡A  [Highly expressed CD147 on CD4⁺ tumor infiltrating lymphocytes promotes the progress of breast cancer]‏ ‎‡9  1‏
919 ‎‡a  cd147reinforces1oscillationsandpromotesoncogenicprogressioninhepatocellularcarcinoma‏ ‎‡A  CD147 reinforces [Ca2+]i oscillations and promotes oncogenic progression in hepatocellular carcinoma‏ ‎‡9  1‏
919 ‎‡a  tcrrepertoireandcdr3motifanalysesdepicttheroleofαβtcellsinankylosingspondylitis‏ ‎‡A  TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis‏ ‎‡9  1‏
919 ‎‡a  conversionofeffectorcd4+tcellstoacd8+mhc2recognizinglineage‏ ‎‡A  Conversion of effector CD4+ T cells to a CD8+ MHC II-recognizing lineage‏ ‎‡9  1‏
919 ‎‡a  rip3promotescolitisassociatedcolorectalcancerbycontrollingtumorcellproliferationandcxcl1inducedimmunesuppression‏ ‎‡A  RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression‏ ‎‡9  1‏
919 ‎‡a  novelantibodyepitopesdominatetheantigenicityofspikeglycoproteininsarscov2comparedtosarscov‏ ‎‡A  Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV‏ ‎‡9  1‏
919 ‎‡a  functionaldefectsincd4+cd25highfoxp3+regulatorycellsinankylosingspondylitis‏ ‎‡A  Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis‏ ‎‡9  1‏
996 ‎‡2  DNB|1121046746
996 ‎‡2  CYT|AC000268224
996 ‎‡2  PLWABN|9810562470905606
996 ‎‡2  ISNI|000000038179836X
996 ‎‡2  ISNI|0000000075322427
996 ‎‡2  CYT|AC000636190
996 ‎‡2  DNB|1265492603
996 ‎‡2  SUDOC|280200951
996 ‎‡2  SUDOC|177472405
996 ‎‡2  CYT|AC000637750
996 ‎‡2  LC|no2009130338
996 ‎‡2  LC|nr 92021029
996 ‎‡2  ISNI|0000000020995085
996 ‎‡2  NUKAT|n 2014000408
996 ‎‡2  ISNI|0000000063225259
996 ‎‡2  NDL|01096565
996 ‎‡2  DNB|138685193
996 ‎‡2  LC|no2011178777
996 ‎‡2  LC|no2008009217
996 ‎‡2  DNB|1168450608
996 ‎‡2  DNB|1322202613
996 ‎‡2  DNB|1165170698
996 ‎‡2  BNF|16165976
996 ‎‡2  LC|n 84005520
996 ‎‡2  CYT|AC000636142
996 ‎‡2  DNB|1082298441
996 ‎‡2  SUDOC|169319318
996 ‎‡2  DNB|1295216892
996 ‎‡2  CYT|AC000010941
996 ‎‡2  BNF|16025767
996 ‎‡2  ISNI|0000000357742139
996 ‎‡2  NTA|272563994
996 ‎‡2  DNB|123578876
996 ‎‡2  LC|nr 95028481
996 ‎‡2  LC|n 2013187364
996 ‎‡2  NTA|152360476
996 ‎‡2  ISNI|0000000383700266
996 ‎‡2  DNB|1095254855
996 ‎‡2  CAOONL|ncf10377303
996 ‎‡2  PLWABN|9812802083105606
996 ‎‡2  NDL|00403732
996 ‎‡2  DNB|127271487X
996 ‎‡2  CYT|AC000386532
996 ‎‡2  ISNI|0000000451019094
996 ‎‡2  CYT|AC000650287
996 ‎‡2  SUDOC|142451711
996 ‎‡2  PLWABN|9811788062105606
996 ‎‡2  CYT|AC000663370
996 ‎‡2  CYT|AC000662442
996 ‎‡2  ISNI|0000000499216425
996 ‎‡2  NTA|204476917
996 ‎‡2  CAOONL|ncf11203262
996 ‎‡2  RERO|A000179147
996 ‎‡2  ISNI|0000000032863485
996 ‎‡2  DNB|1279104147
996 ‎‡2  DNB|1207439401
996 ‎‡2  LC|no2007153609
996 ‎‡2  DNB|1166175162
996 ‎‡2  SUDOC|077473191
996 ‎‡2  CYT|AC000637304
996 ‎‡2  DNB|130350079
996 ‎‡2  DNB|1123222363
996 ‎‡2  BNF|14454310
996 ‎‡2  LC|n 85094184
996 ‎‡2  DNB|1255096829
996 ‎‡2  NDL|01142601
996 ‎‡2  DNB|1241121141
996 ‎‡2  ISNI|0000000416599206
996 ‎‡2  DNB|1080679138
996 ‎‡2  J9U|987012679140605171
996 ‎‡2  DNB|1302860798
996 ‎‡2  ISNI|0000000081853080
996 ‎‡2  ISNI|0000000073322925
996 ‎‡2  ISNI|0000000047106364
996 ‎‡2  DNB|1280184450
996 ‎‡2  DNB|1141199165
996 ‎‡2  ISNI|0000000037373776
996 ‎‡2  NII|DA19461279
996 ‎‡2  NTA|364162007
996 ‎‡2  LC|n 99830839
996 ‎‡2  LC|nr2001013286
996 ‎‡2  SUDOC|129336416
996 ‎‡2  CAOONL|ncf11884567
996 ‎‡2  DNB|1317783336
996 ‎‡2  LC|no2024092932
996 ‎‡2  BNF|14553100
996 ‎‡2  LC|no2018061241
996 ‎‡2  J9U|987007314532505171
996 ‎‡2  DNB|1191949591
996 ‎‡2  LC|no2013078704
996 ‎‡2  CYT|AC000636967
996 ‎‡2  CAOONL|ncf10358787
996 ‎‡2  ISNI|0000000074888170
996 ‎‡2  ISNI|0000000054356230
996 ‎‡2  DNB|1318131901
996 ‎‡2  SUDOC|227583752
996 ‎‡2  LC|n 93083419
996 ‎‡2  CYT|AC000324379
996 ‎‡2  ISNI|0000000047584761
996 ‎‡2  DNB|1151907197
996 ‎‡2  DNB|1139510282
996 ‎‡2  LC|no2007118474
996 ‎‡2  DNB|1306558212
996 ‎‡2  DNB|1320653820
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏